Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
DP64, We got an update at the start of the month that finished with "A further announcement will be made by the Company at the appropriate time."
Provexis is waiting on information from more than 50 actual and prospective customers and also the outsourced manufacturer of Fruitflow before it can take the next steps wrt stock.
I am sure we will be told when this is finalised.
Well well well. So much information about BH. Very good for BH share holders. What is happening to PXS share holder? It is keep on going down. Our good friend IF is happily drawing his handsome salary and being share holders we are just suc@@@@ our thumbs and watching the sp keep on sliding. Come on IF do something and update what is happening with our beloved FF.
Ha ha meant PXS(I'll read an RNS
Previously, BY-HEALTH has successively released the research results of the world's leading anti-aging substance PCC1, the first large-scale study on NAD+ and aging in the Chinese population, and the research results of Qingluosu on improving blood flow health in the Chinese population. Functions and new technologies, including the patented strain LPB27, which has been independently developed for 7 years, have been implemented on the product side.
Last week, BY-HEALTH's sub-brand Yep achieved a breakthrough in raw material technology and released the GAGs collagen peptide product. It continues to create differentiated
No idea.
It may tell you in the first quarter report.
http://data.eastmoney.com/notices/detail/300146/AN202304261585891420.html
or maybe the Annual Audit Report
http://data.eastmoney.com/notices/detail/300146/AN202303171584352048.html
but I don't fancy reading them to find out.
What's the cash position please?
"BY-HEALTH: First-quarter revenue and profit both hit record highs in a single quarter"
"The company's revenue and profit both hit a record high in a single quarter, and the growth rate exceeded market expectations. Data show that in the first quarter of this year, BY-HEALTH achieved an operating income of 3.108 billion yuan, a year-on-year increase of 36.30%, and a net profit of 1.03 billion yuan, a year-on-year increase of 55.27%."
"Among them, BY-HEALTH's main brand achieved revenue of 1.878 billion yuan, a year-on-year increase of 45.41%"
https://www.stcn.com/article/detail/852884.html
Qingluosu even gets a mention.
I do not think the 3m is a trade . It is probably a transfer between two parties.
Cant they find a better image to use. Pffft.
There we go, that didn't take long. 0.6455
It probably won't take long for the delayed 3 million sell to work it's way through the system.
I paid 0.67 this morning.
Quoted 0.668 to buy. I might wait a couple of days & see if it drops below 0.65 again.
I bought more of these at 0.6485 in October which I then sold for 0.9684 in January to reduce my average (well, my wife's average in this case but she doesn't know...). Now that we're back in the 0.60 - 0.70 range, notwithstanding the upcoming £6m profit previously discussed here, I'm wondering whether to try the same trick again. I'll see what I get quoted to buy.
Now might be he appropriate time please Bh
No. By-Health are aiming to get the 25th health function claim.
"By-Health continues to work on an extensive regulatory submission to the Chinese State Administration for Market Regulation (SAMR) for Fruitflow, seeking to establish a new permitted health function claim for foods such as Fruitflow that can demonstrate an anti-platelet effect, addressing the aberrant blood clots which can lead to heart attacks and strokes."
"By-Health will file its regulatory submission to the SAMR for Fruitflow at the appropriate time, seeking to obtain a new permitted health function claim which would be in addition to the currently defined list of 27 (reducing to 24) permitted claims. Subject to the timing the new anti-platelet claim, if approved, would therefore represent the 28th - or the 25th - permitted health function claim in China."
https://www.investegate.co.uk/provexis-plc/rns/half-year-report/202212300853083258L/
Thanks for posting the original text. So are we "assisting blood lipids reduction" group?
Health food registration:
Since the repeal of Technical Standards for Testing & Assessment of Health Food (2003 Edition) in 2018, most of the registrations of new health food products in China have been suspended due to a lack of testing basis for functional evaluation.
However, according to ??????[2012] No. 107 (National Food and Drug Administration [2012] No. 107), nine health function evaluation methods are currently valid, these are:
antioxidant;
assisting the protection from gastric mucosal injury;
assisting blood sugar reduction;
alleviating visual fatigue;
improving iron-deficiency anemia;
assisting blood lipids reduction;
alleviating lead excretion;
reducing body weight; and
clearing and nourishing the throat.
Moreover, several new regulations on evaluation methods of health food functions were issued for public comments on November 24, 2020, and January 13, 2022. We believe that the new evaluation methods can be implemented in the very near future, and products with the 24 permitted health functions can be registered smoothly.
sphnix,
It seems my laptop gives alert about virus when I click the link. What is the link about?
https://www.cirs-group.com/en/food/faqs-on-health-food-registration-and-filing-in-china
Just grabbed another 301k . Never thought I would buy again at below 0.70.
DP64, alfista is correct. DSM outsourced the manufacture of Fruitflow and as of the 1st of January we are now in control of the manufacturer.
" DSM will help facilitate the transfer of its wholly outsourced supply chain / production process for Fruitflow from DSM to Provexis with effect from 1 January 2023"
https://www.investegate.co.uk/provexis-plc/rns/half-year-report/202212300853083258L/
DSM have never produced Fruitflow.
The contact with the manufacturer is longstanding . Absolutely no change whatsoever, Provexis will buy all Fruitflow to sell.
gixer,
I have a very simple question. Who will produce FF in future when DSM's current stock finish. If it is DSM's machinery then they will mark a price to produce it. I do not think PXS has the ability to produce FF. Another option is BH will produce FF under the license of PXS. May be IF need to update what is in his mind about the future direction!!!